Furuya, H., Sasaki, Y., Chen, R., Peres, R., Hokutan, K., Murakami, K., Kim, N., Chan, O. T. M., Pagano, I.
, Dyrskjøt, L., Jensen, J. B., Malmstrom, P. U., Segersten, U., Sun, Y., Arab, A., Goodarzi, H., Goodison, S. & Rosser, C. J. (2022).
PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity.
Scientific Reports,
12(1), Article 12186.
https://doi.org/10.1038/s41598-022-16518-3
Siltari, A., Riikonen, J., Koskimäki, J., Pakarainen, T., Ettala, O., Boström, P., Seikkula, H., Kotsar, A., Tammela, T., Helminen, M., Raittinen, P. V., Lehtimäki, T., Fode, M., Østergren, P.
, Borre, M., Rannikko, A., Marttila, T., Salonen, A., Ronkainen, H. ... Murtola, T. J. (2022).
Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol.
BMJ Open,
12(4), Article e050264.
https://doi.org/10.1136/bmjopen-2021-050264
Bhattacharya, I., Seetharaman, A., Kunder, C., Shao, W., Chen, L. C.
, Soerensen, S. J. C., Wang, J. B., Teslovich, N. C., Fan, R. E., Ghanouni, P., Brooks, J. D., Sonn, G. A. & Rusu, M. (2022).
Selective identification and localization of indolent and aggressive prostate cancers via CorrSigNIA: an MRI-pathology correlation and deep learning framework: CorrSigNIA: an MRI-pathology correlation and deep learning framework.
Medical Image Analysis,
75, Article 102288.
https://doi.org/10.1016/j.media.2021.102288